Terms: = Liver cancer AND RBM15, Q96T37, 64783, ENSG00000162775, OTT, OTT1 AND Prognosis
4 results:
1. m6A-Related Genes Contribute to Poor prognosis of Hepatocellular Carcinoma.
Zou Y; Jiang G; Xie Y; Li H
Comput Math Methods Med; 2022; 2022():2427987. PubMed ID: 36339682
[TBL] [Abstract] [Full Text] [Related]
2. Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response.
Jiang H; Ning G; Wang Y; Lv W
Dis Markers; 2021; 2021():5576683. PubMed ID: 34221187
[TBL] [Abstract] [Full Text] [Related]
3. The cancer Genome Atlas (TCGA) based m
Liu J; Sun G; Pan S; Qin M; Ouyang R; Li Z; Huang J
Bioengineered; 2020 Dec; 11(1):759-768. PubMed ID: 32631107
[TBL] [Abstract] [Full Text] [Related]
4. The significance of m6A RNA methylation regulators in predicting the prognosis and clinical course of HBV-related hepatocellular carcinoma.
Fang Q; Chen H
Mol Med; 2020 Jun; 26(1):60. PubMed ID: 32552682
[TBL] [Abstract] [Full Text] [Related]
